Leap Therapeutics Inc (NASDAQ: LPTX) kicked off on Tuesday, up 32.17% from the previous trading day ,before settling in for the closing price of $2.58. Over the past 52 weeks, LPTX has traded in a range of $1.24-$10.20.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -20.00% over the last five years. While this was happening, its average annual earnings per share was recorded 43.40%. With a float of $23.42 million, this company’s outstanding shares have now reached $25.57 million.
The firm has a total of 54 workers. Let’s measure their productivity.
Leap Therapeutics Inc (LPTX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Leap Therapeutics Inc is 8.50%, while institutional ownership is 23.98%.
Leap Therapeutics Inc (LPTX) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/30/2023, the organization reported -$0.46 earnings per share (EPS), higher than consensus estimate (set at -$0.55) by $0.09. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.62 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -2.49% during the next five years compared to 28.36% growth over the previous five years of trading.
Leap Therapeutics Inc (NASDAQ: LPTX) Trading Performance Indicators
Take a look at Leap Therapeutics Inc’s (LPTX) current performance indicators. Last quarter, stock had a quick ratio of 5.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.12, a number that is poised to hit -0.58 in the next quarter and is forecasted to reach -1.49 in one year’s time.
Technical Analysis of Leap Therapeutics Inc (LPTX)
Analysing the last 5-days average volume posted by the [Leap Therapeutics Inc, LPTX], we can find that recorded value of 0.34 million was better than the volume posted last year of 0.24 million. As of the previous 9 days, the stock’s Stochastic %D was 49.22%. Additionally, its Average True Range was 0.29.
During the past 100 days, Leap Therapeutics Inc’s (LPTX) raw stochastic average was set at 56.56%, which indicates a significant decrease from 86.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 138.98% in the past 14 days, which was higher than the 114.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.80, while its 200-day Moving Average is $2.52. Now, the first resistance to watch is $3.80. This is followed by the second major resistance level at $4.20. The third major resistance level sits at $4.80. If the price goes on to break the first support level at $2.80, it is likely to go to the next support level at $2.20. Now, if the price goes above the second support level, the third support stands at $1.80.
Leap Therapeutics Inc (NASDAQ: LPTX) Key Stats
The company with the Market Capitalisation of 87.30 million has total of 25,600K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -81,410 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -12,470 K.
